Thus, it is possible that LTBP-2 may also influence TGF-β bioavailability, supported by observations that some individuals with LTBP-2 mutations exhibit Marfan Syndrome-like characteristics linked to aberrant TGF-β upregulation [18,19]. The gene discussed is TGFB1; the disease is Marfan syndrome.